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Blood-contacting devices coated with anti-clotting materials would typically fail due to clot formation after about 2 weeks of exposure to blood flow. Our overarching hypothesis for their short-term success is that the failure modes of these anti-clotting coatings are either due to 1) a slowed-pace procoagulant protein fouling, 2) their erosion due to shear stress, or 3) a combination of both. This study however partly tests the hypothesis by evaluating the effect of shear stress on coating stability. This was done by exposing DOPA-PCB-300/dopamine coated polydimethylsiloxane (PDMS) to physiological shear stresses using a recirculation system which consisted of dual chamber acrylic flow cells, tygon tubing, flow probe and meter, and perfusion pumps.
The effect of shear stress induced by phosphate buffered saline flow on coating stability was characterized with differences in fibrinogen adsorption between control (coated PDMS not loaded with shear stress) and coated samples loaded with various shear stresses. Fibrinogen adsorption data showed that relative adsorption on coated PDMS that weren't exposed to shear (5.73% ± 1.97%) was significantly lower than uncoated PDMS (100%, p < 0.001). Furthermore, this fouling level, although lower, was not significantly different from coated PDMS membranes that were exposed to 1 2 (9.55% ± 0.09%, p = 0.23), 6 2 (15.92% ± 10.88%, p = 0.14), and 10 2 (21.62% ± 13.68%, p = 0.08). Our results show that DOPA-PCB-300/dopamine coating are stable, with minimal erosion, under shear stresses tested.
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Large quantities of blood-contacting medical devices are used annually world-wide. 1, 2 It is estimated that more than 200 million of these devices are utilized in patients in the U.S alone. 3 They range from devices with small surface areas like catheters, vascular grafts, heart valves, cannulas, glucose, lactate sensors, and stents to those with moderate surface areas like pacemakers, artificial kidneys, and left ventricular assist devices. Then there are those with relatively larger surface areas like the artificial lungs, artificial hearts, and extracorporeal membrane oxygenation circuits.
The surfaces of these devices are made up of artificial materials that are different from endothelial cell surfaces, which interface with flowing blood. 4−6 These cells express enzymes and secrete nitric oxide that maintain blood tone. 7−10 Without these properties, blood rapidly activates into clots upon contact with artificial materials. 11, 12 For bloodcontacting devices, clot formation can cause cessation of blood flow and lead to device failure 13−15 . Moreover, devices that do not fail may release clots into systemic circulation and cause embolic complications. 14, 16−18 In life support devices these clots can result in morbidity and mortality. For instance, a small bore vascular graft serving as a coronary artery may occlude from formation and cause myocardial infarction (heart attack). With artificial lungs, clotting is especially problematic as they have relatively large surface
) and a period of usage lasting from several weeks to months however they typically fail after 7-14 days with accompanying hemorrhagic complications. [13] [14] [15] 18 Catheters, on the other hand, have a limited lifespan and do not reliably allow repeated sampling of blood or continuous pressure monitoring in patients as their small lumen diameters make them more prone to failure by clots 19−22 . 41 and sulfobetaine 42 that have undergone extensive human clinical evaluation have shown no drastic non-thrombogenic benefit compared to existing heparin-coated materials. 43, 44 Systemic anticoagulants hence remain the adjunctive therapy of choice although they pose an increased risk of bleeding complications. 45−47 Important factors that affect the efficiency these coatings include their stability and coverage on devices and mechanism(s) of inhibiting coagulation. Coatings that become unstable and erode against fluid shear progressively lose their anticoagulation activity and imperfections in coating can weaken the anti-coagulation effectiveness, as procoagulant proteins can adsorb at uncoated spots. Our overall hypothesis for their short-term success is that the failure modes of these anti-clotting coatings are either due to 1) a slowed-pace procoagulant protein fouling, 2) their erosion due to shear stress, or 3) a combination of both. To test our hypothesis, a relatively new coating material that has shown ultra-low auto-adsorption of pro-coagulant proteins, polycarboxybetaine, [48] [49] [50] was used to study the effect of shear stress on coating stability. PDMS coated with DOPA-PCB-300/dopamine were exposed to shear stresses similar to those found in the vena cava, large veins, and conduit arteries. adhesive nitrile sponge rubber gasket (Grainger.com, Lake Forest, IL) followed by the application of a gasket-lined top mate and compression of top and bottom mates with screws.
To ensure no leakages during application of flows over samples, a leak test was performed under experimental test conditions. A PDMS sample measuring 8.89 x 2.54 was inserted into the recirculation circuit and primed with 35mL of phosphate buffered saline (PBS) ensuring that no air bubbles were present in the circuit before flow initiation.
Recirculation was maintained for 8 hours at low flow (30 ) and high flow (1500 ). Since the blood perfusion pumps used in this experiment are roller pumps that display only digital revolutions per minute (rpm) readouts, it was necessary to determine their flow rates as a function of rpms. First, their tubing occlusion were set at the recommended clinical pump occlusion setting where a 100cm fluid column drops 25cm/min [52] [53] . At this occlusion setting, a calibration curve of rpm versus flow rates was generated by pumping of PBS from a reservoir to an empty container. Rpms were set at 50, 100, and 150 and the pumped volume and pumping time recorded. An rpm to flow rate calibration curve was generated for each pump so that a relation of wall shear stress as a function average flow velocity (flow rate/cross sectional area), fluid dynamic viscosity, and hydraulic diameter of flow chamber could be developed. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Darcy-Wiesbach friction factor for the acrylic chamber surface is = were casted via two-part polymerization process. Cured PDMS membranes were coated with DOPApCB-300 using a dip-coating process previously described. 50 . The membranes were carefully removed after recirculation and stored in PBS. Three 1 x 1 pieces from each sample were sectioned and prepared for standard fibrinogen adsorption ELISA as previously described. 50 The circuits were soaked in 10% bleach overnight, rinsed with DI water and dried with pressurized nitrogen between test runs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 cuvettes. The absorbance of each supernatant was then measured at 492 using UV-vis spectrophotometer (Beckman Coulter, CT). It was expected that uncoated PDMS samples would have higher absorption of fibrinogen and thus higher UV-vis absorbance levels. The effect of coating erosion on biocompatibility was determined as the percent increase in fibrinogen adsorption compared to appropriate DOPAPCB-300/dopamine coated PDMS controls. Less than 10% increment was considered highly stable, between 10 -30% increase was considered stable and 30% or greater was considered unstable.
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A single factor ANOVA (SPSS, Chicago IL) was run to determine statistical differences between controls (uncoated PDMS, and DOPApCB-300/dopamine coated PDMS with no flow) and coated PDMS exposed to 1 2 , 6 2 and 10 2 shear stresses. A < 0.05 was regarded as significant.
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The exploded view of the flow cell design showing top and bottom mates, cell chamber, gasket channel circuit connectors are shown in (! and (+ ( are the flow cell and recirculation circuit prototypes. There were also no observable leaks or air bubbles in the circuit during all runs. The 5 syringe in Figure 3C was used to Langmuir   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 prime and extract trapped bubbles during priming.
As presented in ,, the rpm to flow rate calibration of pumps showed linear relationships between the two variables although there were some pump-pump variation 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 date, it was determined that the calculated wall shear, , increased with flow rate according to = .. . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 or laminar flows, it was also deduced that almost all of the sample surface area saw constant non-zero shear stresses during flow. However, in the entrance region isn't constant but rather starts out larger before decreasing to a constant stress in the fully 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 dynes/cm 2 (9.55% ± 0.09%, p = 0.23), 6 dynes/cm 2 (15.92% ± 10.88%, p = 0.14), and 10 2 (21.62% ± 13.68%, p = 0.08). Our findings show that DOPApCB-300/dopamine coating were stable under the test conditions and only minimal coating erosion was observed. Compared to the coated PDMS no shear stress case, coated surfaces that were exposed to 1, 6, and 10 2 of shear stress, adsorbed 3.83%, 10.20%, and 15.90% more fibrinogen respectively. It should be noted that the experiment was conducted at room temperature and with pH 7 PBS which are different from in-vivo conditions where the surface will interact with blood flow at a higher temperature. The study design used here however allows for a direct measurement of nonspecific protein adsorption on coated model surfaces after they have been exposed to flow, allowing for quantification of the stability of any non-fouling coating or surface immobilized enzymes against shear stress. Contamination of sample surfaces with biological material from stability testing with whole blood and perhaps plasma, on the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 other hand, could lead to unreliable coating stability data using this approach. Nonspecific protein fouling on coatings exposed to blood or plasma flow shear stress would be simply difficult to evaluate.
In this study, the stability of a low-fouling DOPA-PCB-300/dopamine coating against various flow-induced shear stresses was measured. It was found that instability, as between shear stress and no shear stress coated samples were compared to determine differences. Less than 10% increment was considered highly stable, between 10 -30% increase was considered stable and 30% or greater was considered unstable.
Compared to the coated PDMS with no shear stress case, coated surfaces that were exposed to 1, 6, and 10 2 of shear stress, respectively adsorbed 3.83%, 10.20%, and 15.90% more fibrinogen. Our results therefore show that DOPApCB-300/dopamine coating were stable and only minimal coating erosion was observed. As newer and more robust anticlotting coatings get developed, this simple and easy-to-use in-vitro flow cell system provides an appropriate pre-in vivo screening tool for determining coating stability under flow before conducting animal testing. The flow system can be used to evaluate many coatings and surface modifications in biomaterials and blood-contacting devices. Other biomarkers for blood coagulation can be studied with this flow cell as well as evaluating the effects of pH and temperature. .
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